Profile | GDS5420 / AFFX-r2-Bs-thr-5_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 272.24 | 57 |
GSM1296119 | B_lesional_pre-dose | 118.4 | 43 |
GSM1296076 | C_lesional_pre-dose | 83.74 | 39 |
GSM1296092 | D_lesional_pre-dose | 91.19 | 42 |
GSM1296103 | E_lesional_pre-dose | 348.17 | 61 |
GSM1296078 | F_lesional_pre-dose | 84.84 | 40 |
GSM1296107 | G_lesional_pre-dose | 146.98 | 46 |
GSM1296109 | H_lesional_pre-dose | 257.12 | 55 |
GSM1296080 | I_lesional_pre-dose | 340.98 | 62 |
GSM1296090 | J_lesional_pre-dose | 99.04 | 43 |
GSM1296074 | K_lesional_pre-dose | 71.14 | 39 |
GSM1296111 | L_lesional_pre-dose | 125.78 | 43 |
GSM1296099 | M_lesional_pre-dose | 169.24 | 49 |
GSM1296086 | O_lesional_pre-dose | 108.93 | 44 |
GSM1296117 | P_lesional_pre-dose | 132.04 | 44 |
GSM1296113 | Q_lesional_pre-dose | 181.81 | 49 |
GSM1296096 | R_lesional_pre-dose | 179.26 | 51 |
GSM1296105 | S_lesional_pre-dose | 205.82 | 52 |
GSM1296098 | T_lesional_pre-dose | 398.84 | 64 |
GSM1296101 | U_lesional_pre-dose | 283.61 | 58 |
GSM1296121 | V_lesional_pre-dose | 149.92 | 47 |
GSM1296088 | W_lesional_pre-dose | 196.92 | 53 |
GSM1296082 | X_lesional_pre-dose | 94.78 | 42 |
GSM1296115 | Y_lesional_pre-dose | 159.98 | 48 |
GSM1296084 | Z_lesional_pre-dose | 254.76 | 56 |
GSM1296072 | B_lesional_day8 | 110.06 | 41 |
GSM1296069 | L_lesional_day8 | 168.17 | 47 |
GSM1296071 | P_lesional_day8 | 150.01 | 45 |
GSM1296070 | Y_lesional_day8 | 160.25 | 47 |
GSM1296073 | V_lesional_day8 | 90.36 | 39 |
GSM1296034 | A_lesional_day15 | 724.2 | 73 |
GSM1296041 | G_lesional_day15 | 131.2 | 45 |
GSM1296035 | R_lesional_day15 | 209.84 | 53 |
GSM1296038 | U_lesional_day15 | 204.28 | 53 |
GSM1296047 | B_lesional_day15 | 169.77 | 48 |
GSM1296039 | E_lesional_day15 | 90.76 | 40 |
GSM1296042 | H_lesional_day15 | 133.58 | 44 |
GSM1296043 | L_lesional_day15 | 156.19 | 46 |
GSM1296037 | M_lesional_day15 | 278.07 | 57 |
GSM1296046 | P_lesional_day15 | 159.51 | 47 |
GSM1296044 | Q_lesional_day15 | 153.63 | 46 |
GSM1296045 | Y_lesional_day15 | 162.87 | 47 |
GSM1296025 | C_lesional_day15 | 219.1 | 54 |
GSM1296033 | D_lesional_day15 | 151.67 | 48 |
GSM1296027 | I_lesional_day15 | 45.12 | 32 |
GSM1296032 | J_lesional_day15 | 285.75 | 58 |
GSM1296024 | K_lesional_day15 | 112.03 | 44 |
GSM1296031 | W_lesional_day15 | 356.69 | 61 |
GSM1296028 | X_lesional_day15 | 139.28 | 47 |
GSM1296029 | Z_lesional_day15 | 342.61 | 61 |
GSM1296026 | F_lesional_day15 | 98.44 | 42 |
GSM1296030 | O_lesional_day15 | 104.96 | 45 |
GSM1296040 | S_lesional_day15 | 396.52 | 63 |
GSM1296036 | T_lesional_day15 | 388.76 | 63 |
GSM1296048 | V_lesional_day15 | 149.01 | 47 |
GSM1296059 | A_lesional_day43 | 182.1 | 51 |
GSM1296066 | G_lesional_day43 | 151.68 | 46 |
GSM1296060 | R_lesional_day43 | 176.56 | 50 |
GSM1296063 | U_lesional_day43 | 115.1 | 43 |
GSM1296064 | E_lesional_day43 | 146.26 | 48 |
GSM1296067 | H_lesional_day43 | 185.88 | 49 |
GSM1296062 | M_lesional_day43 | 295.7 | 58 |
GSM1296068 | Q_lesional_day43 | 181.74 | 48 |
GSM1296050 | C_lesional_day43 | 142.31 | 47 |
GSM1296057 | D_lesional_day43 | 153.48 | 48 |
GSM1296052 | I_lesional_day43 | 72.84 | 39 |
GSM1296054 | J_lesional_day43 | 318.2 | 59 |
GSM1296049 | K_lesional_day43 | 227.38 | 55 |
GSM1296055 | W_lesional_day43 | 201.69 | 52 |
GSM1296053 | X_lesional_day43 | 197.34 | 52 |
GSM1296058 | Z_lesional_day43 | 144.56 | 48 |
GSM1296051 | F_lesional_day43 | 109.57 | 44 |
GSM1296056 | O_lesional_day43 | 129.24 | 47 |
GSM1296065 | S_lesional_day43 | 108.89 | 42 |
GSM1296061 | T_lesional_day43 | 618.44 | 71 |
GSM1296095 | A_non-lesional_pre-dose | 174.63 | 51 |
GSM1296120 | B_non-lesional_pre-dose | 145.53 | 46 |
GSM1296077 | C_non-lesional_pre-dose | 112.88 | 44 |
GSM1296093 | D_non-lesional_pre-dose | 400.28 | 63 |
GSM1296104 | E_non-lesional_pre-dose | 176.14 | 50 |
GSM1296079 | F_non-lesional_pre-dose | 183.72 | 52 |
GSM1296108 | G_non-lesional_pre-dose | 184.03 | 50 |
GSM1296110 | H_non-lesional_pre-dose | 197.68 | 50 |
GSM1296081 | I_non-lesional_pre-dose | 464.38 | 67 |
GSM1296091 | J_non-lesional_pre-dose | 123.79 | 46 |
GSM1296075 | K_non-lesional_pre-dose | 96.8 | 42 |
GSM1296112 | L_non-lesional_pre-dose | 169.23 | 47 |
GSM1296100 | M_non-lesional_pre-dose | 550.46 | 69 |
GSM1296087 | O_non-lesional_pre-dose | 32.35 | 26 |
GSM1296118 | P_non-lesional_pre-dose | 224.58 | 53 |
GSM1296114 | Q_non-lesional_pre-dose | 216.99 | 52 |
GSM1296097 | R_non-lesional_pre-dose | 167.93 | 49 |
GSM1296106 | S_non-lesional_pre-dose | 224.89 | 53 |
GSM1296102 | U_non-lesional_pre-dose | 352.45 | 61 |
GSM1296122 | V_non-lesional_pre-dose | 210.98 | 52 |
GSM1296089 | W_non-lesional_pre-dose | 267.36 | 56 |
GSM1296083 | X_non-lesional_pre-dose | 662.25 | 72 |
GSM1296116 | Y_non-lesional_pre-dose | 159.23 | 46 |
GSM1296085 | Z_non-lesional_pre-dose | 128.72 | 45 |